Tech Company Financing Transactions
Swing Therapeutics Funding Round
Swing Therapeutics closed a $10.3 million Series A funding round on 6/17/2022. Investors included JAZZ Venture Partners, Alumni Ventures and AME Cloud Ventures.
Transaction Overview
Company Name
Announced On
6/17/2022
Transaction Type
Venture Equity
Amount
$10,300,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support the execution of the PROSPER-FM randomized clinical trial and to launch an affiliated telemedicine clinic.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
353 Sacramento St. 1803
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Website
Email Address
Not Recorded
Overview
At Swing, our mission is to create evidence-backed digital treatments to help people with chronic conditions live their best lives. The results of our initial studies are encouraging, and with the support of the FDA, we look forward to optimizing the product as we advance through our pivotal trial. Learn more about the team bringing our digital treatments to life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Rosenbluth
Chief Medical Officer
Michael Gendreau
VP - Engineering
Eric Hoppe
VP - Operations
Jeremy Frank
VP - Product Management
Nelson Mitchell
Browse more venture capital transactions:
Prev: 6/17/2022: FanClash venture capital transaction
Next: 6/18/2022: Webio venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs